Search Results

Mitsubishi Electric Corporation announced that Dr. Shumpei Kameyama of Mitsubishi Electric’s Information Technology R&D Center and Dr. Jonathan Le Roux of Mitsubishi Electric Research Laboratories, Inc. have been awarded the title of IEEE Fellow.

Flagship Pioneering–backed Generate:Biomedicines has signed its second major Big Pharma partnership, bringing in $65 million upfront to use its AI platform to discover novel protein drug candidates.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date.

Ahead of a Senate health committee hearing next week with Novo Nordisk CEO Lars Jørgensen, Sen. Bernie Sanders claims he has secured assurances from generics developers that they will charge a significantly lower monthly price than the $969 Americans currently pay for the Danish drugmaker’s diabetes blockbuster.

OSE Immunotherapeutics SA announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors.

Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces that The International Journal of Technology Assessment in Health Care has recently published an exploratory analysis entitled “Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea.”

Zynex, Inc today announced that it has received clearance from the U.S. Food and Drug Administration (“FDA”) for the next generation M-Wave Neuromuscular Electrical Stimulation (“NMES”) device.